Vincent J. Picozzi

机构：Virginia Mason Medical Center

发表论文 238 篇 · 总被引 7503 次 · h-index 40

代表论文

• Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study (2025 · Journal of Clinical Oncology · 被引 44)
• Efficacy and safety of abemaciclib alone and with PI3K / mTOR inhibitor LY3023414 or galunisertib versus chemotherapy in previously treated metastatic pancreatic adenocarcinoma: A randomized controlled trial (2023 · Cancer Medicine · 被引 20)
• Avutometinib/defactinib and gemcitabine/nab-paclitaxel combination in first-line metastatic pancreatic ductal adenocarcinoma: Initial safety and efficacy of phase 1b/2 study (RAMP 205). (2024 · Journal of Clinical Oncology · 被引 14)
• Keratin 17 is a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma (2024 · American Journal of Clinical Pathology · 被引 9)
• LAPIS: Randomized phase 3 trial of chemotherapy (CTX) with and without pamrevlumab (PAM) for locally advanced pancreatic cancer (LAPC). (2025 · Journal of Clinical Oncology · 被引 7)
• Pancreatic cancer: new approaches to drug therapy (2024 · International Journal of Surgery · 被引 7)